Modernization of Enoxaparin Molecular Weight Determination Using Homogeneous Standards

• Auteurs principaux: Katelyn M. Arnold (Auteur), Stephen J. Capuzzi (Auteur), Yongmei Xu (Auteur), Eugene N. Muratov (Auteur), Kevin Carrick (Auteur), Anita Y. Szajek (Auteur), Alexander Tropsha (Auteur), Jian Liu (Auteur)
• Format: Livre
• Publié: MDPI AG, 2017-07-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Enoxaparin is a low-molecular weight heparin used to treat thrombotic disorders. Following the fatal contamination of the heparin supply chain in 2007-2008, the U.S. Pharmacopeia (USP) and U.S. Food and Drug Administration (FDA) have worked extensively to modernize the unfractionated heparin and eno...